04/07/2022
We had a great discussion today about the EMPEROR-Preserved trial during our Journal Club. SGL2i have been recently approved and added to the guidelines for the treatment of Heart Failure with preserved EF. Do you plan on adding SGL2iS to the medical regimen of your HFpEF & HFmrEF patients?